dCas13d can fuse with hnRNP1, a negative regulator of splicing, to target pathogenic tau pre-mRNA, achieve targeted exon skipping, and decrease the ratio of dysregulated tau in a neuronal model of frontotemporal dementia (Figure 3F) (Konermann et al., 2018). This evidence concerns the gene MAPT and frontotemporal dementia.